The stock surged 11.1% as Amphenol delivered substantial beats across sales, margins, and earnings, supported by record bookings and strong operating leverage despite acquisition-related dilution.
- Record Q2 sales of $8.8 billion, up 55% year-over-year in USD and 30% organically.
- Bookings soared 94% from prior year to $10.7 billion, driving a robust book-to-bill ratio of 1.23.
- Adjusted operating margin expanded 24 basis points year-over-year to 29.8%, reflecting strong operational execution and tariff recovery benefits.
- Adjusted diluted EPS jumped 67% to a record $1.35.
- Operating cash flow was $1.6 billion (88% of net income), with free cash flow at $1.2 billion (68% of net income), underpinning solid cash generation amid rapid growth.
Community Discussion